Study of Paiteling Antibacterial Liquid for Persistent HPV Infection
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests an antibacterial liquid (Paiteling®) to see if it can clear a persistent high-risk HPV infection of the cervix. It may be an option for women whose HPV has lasted 2 years or more and whose cervical biopsy shows only mild changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 65 years old.
- You have had the same high-risk HPV type for at least 2 years (persistent infection).
- Your last cervical biopsy showed only mild changes (chronic cervicitis or low-grade CIN1) — not high-grade changes.
- You have not used any HPV treatments in the past 3 months.
- You are not pregnant, breastfeeding, or planning pregnancy in the next 6 months.
- You do not have other serious health conditions (like diabetes, heart disease, or a weakened immune system).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies 2LPAPI® to see if it helps the body clear high-risk HPV infections in the cervix. It may be an option if you have a current HPV infection with mild/early abnormal cervical findings and can complete follow-up for about a year.
This early (Phase 1) study tests a new treatment for people with long-lasting mild abnormal Pap test results (ASC-US or LSIL) who also have HPV16 found on testing. It aims to find out whether the treatment can be given safely and may affect the HPV and abnormal cell changes.
This study tests a light-based treatment called ALA-PDT to see if it can help clear precancerous cervical changes caused by HPV types 16 or 18. It may be an option to avoid more invasive procedures.
This trial tests whether different batches of the HPV 9-valent vaccine work consistently. It's for Chinese women aged 18 to 30 who have not had any HPV vaccine or abnormal cervical screening results.
This study tests whether DARE-HPV, a new treatment, can help your body clear a persistent human papillomavirus (HPV) infection that hasn't gone away on its own. HPV is a common virus; persistent infection with certain high-risk types can lead to cervical cancer, so clearing it early may prevent future problems.
This study tests an injection called BBM-C101 that may help the body clear a long-lasting HPV 16 or 18 infection and prevent precancerous changes from getting worse. It is for people who have not been helped by standard creams or who prefer not to have surgery.
Hear when a new Persistent HR-HPV Infection of the Cervix trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.